Brief: Centessa Pharmaceuticals reports Q2 results

Centessa Pharmaceuticals

10/08/2022 11:34

Aug 10 (Reuters) - Centessa Pharmaceuticals PLC  260y.F :
    * CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS AND
BUSINESS
HIGHLIGHTS FOR THE SECOND QUARTER OF 2022; PROVIDES PROGRAM
UPDATE FOR ZF874
    * CENTESSA PHARMACEUTICALS PLC - CASH AND CASH EQUIVALENTS
OF
$484.2 MILLION AS OF JUNE 30, 2022; CASH RUNWAY INTO 2026
    * CENTESSA PHARMACEUTICALS PLC- ANNOUNCES DISCONTINUATION OF
ZF874
FOR AATD
    * CENTESSA PHARMACEUTICALS PLC - QTRLY LOSS PER SHARE $0.69
    * CENTESSA PHARMACEUTICALS PLC- EXPECTS TO INITIATE CLINICAL
TRIALS WITH LB101 FOLLOWING PLANNED IND APPLICATION SUBMISSION
LATE THIS YEAR

Source text for Eikon:  ID:nGNX6r0cQz 
Further company coverage:  260y.F